| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
168,032 |
148,694 |
$59.30M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
182,234 |
165,521 |
$53.84M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
67,020 |
58,716 |
$33.37M |
| G0378 |
Hospital observation service, per hour |
11,466 |
9,643 |
$7.99M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
34,752 |
32,417 |
$7.01M |
| 90832 |
Psychotherapy, 30 minutes with patient |
51,437 |
31,040 |
$5.61M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
8,990 |
8,661 |
$5.13M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
20,079 |
1,618 |
$4.83M |
| S9480 |
Intensive outpatient psychiatric services, per diem |
5,576 |
5,218 |
$4.58M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
10,635 |
10,115 |
$3.93M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
29,176 |
26,210 |
$3.73M |
| 70450 |
Computed tomography, head or brain; without contrast material |
26,623 |
24,152 |
$3.48M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
56,993 |
50,342 |
$3.35M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
19,414 |
17,937 |
$3.33M |
| OP710 |
|
17,138 |
15,877 |
$3.22M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
85,753 |
21,345 |
$3.21M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
5,604 |
5,342 |
$2.80M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
11,598 |
10,792 |
$2.75M |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
23,328 |
19,066 |
$2.66M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
54,156 |
45,581 |
$2.60M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
37,912 |
31,706 |
$2.51M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
109,418 |
95,592 |
$2.50M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
39,719 |
9,720 |
$2.46M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
58,873 |
50,276 |
$2.43M |
| 59025 |
Fetal non-stress test |
11,904 |
9,617 |
$2.38M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,884 |
1,845 |
$2.34M |
| OP272 |
|
29,882 |
26,956 |
$2.26M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
53,095 |
44,727 |
$2.26M |
| 80053 |
Comprehensive metabolic panel |
155,476 |
133,452 |
$2.21M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
40,970 |
35,739 |
$2.19M |
| 93458 |
|
1,196 |
1,112 |
$2.04M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
14,990 |
13,947 |
$1.96M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
20,829 |
18,557 |
$1.93M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
944 |
932 |
$1.91M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
2,928 |
2,837 |
$1.78M |
| 93017 |
|
8,570 |
8,169 |
$1.76M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,567 |
2,505 |
$1.63M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,005 |
22,799 |
$1.58M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
193,777 |
159,893 |
$1.54M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
17,329 |
17,117 |
$1.46M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
20,197 |
14,306 |
$1.35M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
5,745 |
5,718 |
$1.32M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
28,732 |
8,832 |
$1.30M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
5,608 |
5,327 |
$1.29M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,985 |
3,781 |
$1.26M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
3,037 |
2,851 |
$1.25M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
24,939 |
22,716 |
$1.18M |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
36,369 |
9,993 |
$1.11M |
| 76818 |
|
8,697 |
3,717 |
$1.09M |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14,574 |
13,873 |
$1.07M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
8,935 |
8,312 |
$1.05M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
20,351 |
19,131 |
$977K |
| OP250 |
|
276,555 |
229,663 |
$966K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
5,001 |
3,037 |
$964K |
| 76830 |
Ultrasound, transvaginal |
9,292 |
8,989 |
$939K |
| 71046 |
Radiologic examination, chest; 2 views |
52,880 |
50,288 |
$914K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
13,676 |
12,074 |
$887K |
| 47562 |
|
366 |
341 |
$833K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
2,021 |
1,924 |
$818K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
46,152 |
40,438 |
$778K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
826 |
737 |
$751K |
| 81422 |
|
1,157 |
1,145 |
$691K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
6,573 |
6,352 |
$658K |
| 71045 |
Radiologic examination, chest; single view |
48,729 |
43,579 |
$657K |
| 92587 |
|
6,540 |
6,470 |
$631K |
| 70486 |
|
3,545 |
3,240 |
$613K |
| 93970 |
|
3,325 |
3,131 |
$611K |
| 90791 |
Psychiatric diagnostic evaluation |
4,487 |
4,380 |
$601K |
| 71250 |
|
3,367 |
3,117 |
$580K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,797 |
2,577 |
$567K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
853 |
561 |
$554K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,348 |
3,122 |
$548K |
| 93971 |
|
5,914 |
5,343 |
$541K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
17,410 |
15,230 |
$502K |
| 76641 |
|
6,006 |
5,824 |
$493K |
| 73564 |
|
10,704 |
10,020 |
$487K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
5,210 |
4,612 |
$482K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13,648 |
10,842 |
$463K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
26,135 |
6,650 |
$448K |
| 93975 |
|
2,321 |
2,227 |
$437K |
| 93798 |
|
10,541 |
1,766 |
$434K |
| 95782 |
|
198 |
193 |
$420K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
4,443 |
2,796 |
$412K |
| 58558 |
|
395 |
386 |
$411K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
37,866 |
31,868 |
$409K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
29,107 |
26,798 |
$408K |
| 88342 |
|
9,578 |
9,184 |
$394K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
1,227 |
1,215 |
$390K |
| 76770 |
|
3,960 |
3,892 |
$389K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
3,263 |
3,186 |
$381K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
10,701 |
10,510 |
$380K |
| 76801 |
|
2,686 |
2,573 |
$376K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
16,562 |
2,652 |
$370K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
1,143 |
979 |
$365K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
510 |
479 |
$361K |
| 97161 |
|
8,486 |
8,012 |
$360K |
| 93880 |
|
2,065 |
1,909 |
$327K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
11,182 |
3,458 |
$320K |
| 77080 |
|
5,144 |
5,045 |
$316K |
| 76536 |
|
3,654 |
3,561 |
$312K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,074 |
1,014 |
$306K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,427 |
4,775 |
$301K |
| 81025 |
|
84,672 |
76,698 |
$300K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
3,293 |
3,205 |
$295K |
| 86900 |
|
30,869 |
27,639 |
$294K |
| 73630 |
|
11,361 |
10,707 |
$278K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
5,450 |
4,188 |
$270K |
| 73130 |
|
9,876 |
8,988 |
$268K |
| 92579 |
|
2,234 |
2,209 |
$257K |
| 73610 |
|
11,195 |
10,284 |
$255K |
| 84484 |
|
54,892 |
44,815 |
$253K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
7,361 |
6,407 |
$249K |
| 77066 |
Tomosynthesis, mammo |
2,329 |
2,270 |
$243K |
| 86850 |
|
24,658 |
21,761 |
$243K |
| 74183 |
|
428 |
410 |
$232K |
| 44970 |
|
144 |
130 |
$232K |
| 92557 |
|
1,709 |
1,701 |
$229K |
| 72110 |
|
5,611 |
5,444 |
$215K |
| 81001 |
|
88,358 |
80,564 |
$214K |
| 86901 |
|
31,080 |
27,634 |
$210K |
| 36415 |
Collection of venous blood by venipuncture |
105,190 |
92,419 |
$208K |
| 73030 |
|
9,289 |
8,632 |
$207K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
168 |
143 |
$206K |
| 92567 |
|
4,340 |
4,275 |
$202K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,635 |
1,293 |
$202K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14,001 |
13,224 |
$196K |
| 96415 |
|
1,366 |
936 |
$195K |
| 81412 |
|
1,277 |
1,272 |
$193K |
| 73110 |
|
7,695 |
6,736 |
$190K |
| 88313 |
|
9,257 |
8,914 |
$188K |
| 76870 |
|
2,467 |
2,367 |
$178K |
| 36430 |
|
2,295 |
1,858 |
$171K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
141 |
137 |
$168K |
| 96409 |
|
703 |
404 |
$168K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
8,639 |
8,274 |
$168K |
| 94644 |
|
5,599 |
4,705 |
$162K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
32,512 |
31,311 |
$161K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
39,173 |
36,072 |
$160K |
| 97165 |
|
2,989 |
2,821 |
$159K |
| 77065 |
Tomosynthesis, mammo |
2,350 |
2,207 |
$158K |
| 92610 |
|
1,701 |
1,605 |
$154K |
| 82962 |
|
50,477 |
35,922 |
$152K |
| 92582 |
|
1,328 |
1,311 |
$151K |
| 76775 |
|
2,134 |
2,057 |
$151K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,890 |
12,105 |
$146K |
| 76813 |
|
1,829 |
1,824 |
$146K |
| 85730 |
|
23,696 |
21,408 |
$144K |
| 10060 |
|
1,906 |
1,786 |
$143K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,311 |
15,735 |
$142K |
| 72131 |
|
1,619 |
1,503 |
$141K |
| 76377 |
|
2,895 |
2,709 |
$140K |
| 73590 |
|
5,375 |
4,856 |
$140K |
| 12011 |
|
1,754 |
1,676 |
$139K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,620 |
2,529 |
$136K |
| J3490 |
Unclassified drugs |
67,854 |
55,694 |
$136K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
17,233 |
13,586 |
$136K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
8,644 |
8,275 |
$134K |
| 70491 |
|
609 |
563 |
$134K |
| 12001 |
|
2,167 |
2,054 |
$133K |
| 97014 |
|
20,234 |
5,167 |
$133K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,022 |
2,010 |
$133K |
| 83690 |
|
37,295 |
33,234 |
$133K |
| 76820 |
|
2,915 |
1,313 |
$131K |
| 74178 |
|
546 |
527 |
$130K |
| 96417 |
|
630 |
400 |
$130K |
| 94375 |
|
2,299 |
2,245 |
$130K |
| 96367 |
|
4,128 |
2,444 |
$130K |
| 84702 |
|
14,668 |
11,751 |
$129K |
| 99215 |
Prolong outpt/office vis |
1,960 |
1,883 |
$129K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
8,650 |
8,283 |
$127K |
| 94726 |
|
2,791 |
2,704 |
$124K |
| 83735 |
|
29,400 |
23,984 |
$121K |
| 73080 |
|
4,899 |
4,297 |
$119K |
| 97162 |
|
2,243 |
2,165 |
$119K |
| 99381 |
|
1,821 |
1,791 |
$116K |
| 80061 |
Lipid panel |
12,936 |
12,217 |
$114K |
| 92523 |
|
1,560 |
1,524 |
$111K |
| C1874 |
Stent, coated/covered, with delivery system |
265 |
213 |
$110K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,978 |
1,918 |
$110K |
| 73700 |
|
905 |
835 |
$109K |
| 96376 |
|
3,553 |
3,094 |
$109K |
| A9270 |
Non-covered item or service |
20,698 |
12,629 |
$106K |
| 72082 |
|
1,932 |
1,926 |
$106K |
| 75574 |
|
368 |
353 |
$104K |
| 90715 |
|
10,135 |
9,686 |
$104K |
| 85027 |
|
14,954 |
13,547 |
$103K |
| 74018 |
|
4,205 |
3,965 |
$102K |
| A0425 |
Ground mileage, per statute mile |
11,616 |
10,683 |
$102K |
| 94729 |
|
2,675 |
2,588 |
$101K |
| A0998 |
Ambulance response and treatment, no transport |
734 |
709 |
$100K |
| 85610 |
|
27,963 |
24,439 |
$100K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12,544 |
11,929 |
$99K |
| 73090 |
|
4,834 |
4,272 |
$99K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
4,613 |
4,369 |
$98K |
| 83880 |
|
8,978 |
7,959 |
$96K |
| 92550 |
|
2,832 |
2,821 |
$96K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,154 |
4,513 |
$96K |
| 72050 |
|
2,355 |
2,302 |
$95K |
| J2704 |
Injection, propofol, 10 mg |
26,271 |
24,607 |
$94K |
| 87070 |
|
15,755 |
15,128 |
$90K |
| J2785 |
Injection, regadenoson, 0.1 mg |
2,357 |
2,153 |
$89K |
| 73560 |
|
2,683 |
2,526 |
$89K |
| 76642 |
|
1,775 |
1,719 |
$88K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
70 |
69 |
$87K |
| A0433 |
Advanced life support, level 2 (als 2) |
278 |
262 |
$87K |
| 86703 |
|
6,231 |
6,038 |
$87K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
5,355 |
5,101 |
$86K |
| 93925 |
|
413 |
380 |
$85K |
| 90837 |
Psychotherapy, 53 minutes with patient |
6,098 |
3,517 |
$84K |
| C1769 |
Guide wire |
3,164 |
2,805 |
$82K |
| 88307 |
|
1,577 |
1,440 |
$82K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
16,829 |
15,563 |
$81K |
| 95886 |
|
1,049 |
1,014 |
$80K |
| 70544 |
|
582 |
515 |
$79K |
| 73502 |
|
4,119 |
3,850 |
$79K |
| 95708 |
|
500 |
402 |
$78K |
| 72100 |
|
2,394 |
2,304 |
$77K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
12,386 |
12,218 |
$77K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
72 |
71 |
$76K |
| 94060 |
|
399 |
380 |
$75K |
| 73140 |
|
3,767 |
3,541 |
$74K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
175 |
173 |
$74K |
| C1781 |
Mesh (implantable) |
80 |
70 |
$74K |
| 95816 |
|
455 |
425 |
$73K |
| 72170 |
|
2,424 |
2,299 |
$71K |
| 86481 |
|
909 |
897 |
$71K |
| 86360 |
|
1,731 |
1,720 |
$70K |
| 72141 |
|
359 |
342 |
$70K |
| 87490 |
|
4,011 |
3,961 |
$70K |
| 87522 |
Neg quan hep c or qual rna |
4,013 |
3,930 |
$69K |
| 72197 |
|
130 |
126 |
$68K |
| 92586 |
|
613 |
609 |
$67K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,590 |
1,324 |
$66K |
| 87535 |
|
1,371 |
1,358 |
$64K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
79,103 |
68,968 |
$62K |
| 97803 |
|
1,090 |
1,038 |
$61K |
| 54161 |
|
59 |
56 |
$61K |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
342 |
281 |
$60K |
| 70498 |
|
687 |
622 |
$60K |
| 83021 |
|
3,182 |
2,981 |
$60K |
| 94010 |
|
373 |
346 |
$59K |
| 88304 |
|
3,246 |
3,070 |
$59K |
| 77062 |
|
1,169 |
1,154 |
$57K |
| 29515 |
|
1,202 |
1,136 |
$56K |
| 87040 |
|
6,751 |
5,836 |
$56K |
| 73552 |
|
2,377 |
2,168 |
$56K |
| 90838 |
|
972 |
929 |
$55K |
| 76000 |
|
1,890 |
1,709 |
$55K |
| 92651 |
|
705 |
696 |
$53K |
| 82728 |
|
6,607 |
5,994 |
$53K |
| OP258 |
|
27,054 |
20,898 |
$52K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
38,210 |
32,837 |
$52K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
810 |
787 |
$52K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
454 |
415 |
$51K |
| 85044 |
|
10,466 |
9,001 |
$51K |
| 77072 |
|
1,540 |
1,528 |
$51K |
| 87186 |
|
8,809 |
8,213 |
$50K |
| 87077 |
|
9,391 |
8,800 |
$50K |
| 81003 |
|
26,123 |
24,374 |
$50K |
| 77336 |
|
684 |
257 |
$49K |
| 76821 |
|
808 |
313 |
$48K |
| 12002 |
|
884 |
828 |
$48K |
| 70496 |
|
674 |
612 |
$48K |
| 94664 |
|
1,013 |
993 |
$48K |
| 84439 |
|
5,091 |
4,784 |
$48K |
| 73060 |
|
2,383 |
2,117 |
$47K |
| C1760 |
Closure device, vascular (implantable/insertable) |
658 |
577 |
$46K |
| 81222 |
|
141 |
138 |
$46K |
| 29125 |
|
1,158 |
1,051 |
$45K |
| 80076 |
|
7,083 |
5,600 |
$45K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
135 |
129 |
$44K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,774 |
1,412 |
$44K |
| 90686 |
|
14,382 |
14,138 |
$43K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
921 |
905 |
$43K |
| 52000 |
|
69 |
64 |
$42K |
| 83605 |
|
7,282 |
6,382 |
$42K |
| 82077 |
|
8,020 |
6,922 |
$41K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
44,130 |
37,382 |
$41K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
2,453 |
2,206 |
$41K |
| 95700 |
|
581 |
562 |
$41K |
| C1889 |
Implantable/insertable device, not otherwise classified |
39 |
36 |
$39K |
| 83615 |
|
7,869 |
6,557 |
$39K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,812 |
698 |
$39K |
| 74019 |
|
1,362 |
1,291 |
$38K |
| 82607 |
|
5,304 |
4,875 |
$37K |
| 84100 |
|
14,167 |
10,862 |
$36K |
| OP270 |
|
4,825 |
4,363 |
$35K |
| J1630 |
Injection, haloperidol, up to 5 mg |
5,346 |
4,196 |
$35K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
10,441 |
8,171 |
$35K |
| 73521 |
|
1,035 |
985 |
$35K |
| 95812 |
|
105 |
105 |
$34K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
577 |
567 |
$33K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,121 |
790 |
$33K |
| 87536 |
|
439 |
438 |
$33K |
| 52356 |
|
13 |
12 |
$33K |
| 66982 |
|
40 |
28 |
$33K |
| 97164 |
|
761 |
713 |
$32K |
| J2060 |
Injection, lorazepam, 2 mg |
5,158 |
4,110 |
$32K |
| S9484 |
Crisis intervention mental health services, per hour |
39 |
39 |
$32K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
5,027 |
2,157 |
$30K |
| 71101 |
|
1,512 |
1,438 |
$30K |
| 87483 |
|
232 |
230 |
$30K |
| 80320 |
|
6,213 |
5,689 |
$30K |
| 87807 |
|
1,581 |
1,548 |
$29K |
| 96523 |
|
228 |
226 |
$29K |
| J1815 |
Injection, insulin, per 5 units |
1,280 |
962 |
$29K |
| 95953 |
|
28 |
26 |
$28K |
| 92526 |
|
604 |
119 |
$28K |
| 86803 |
|
2,175 |
2,043 |
$28K |
| 74240 |
|
296 |
283 |
$27K |
| 76981 |
|
421 |
400 |
$27K |
| 83540 |
|
6,129 |
5,769 |
$27K |
| OP271 |
|
4,080 |
3,911 |
$26K |
| 87081 |
|
3,019 |
2,981 |
$26K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,535 |
2,266 |
$26K |
| 94770 |
|
539 |
539 |
$26K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,053 |
1,039 |
$26K |
| C9600 |
Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
29 |
26 |
$25K |
| 94727 |
|
960 |
958 |
$25K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
23,066 |
21,468 |
$25K |
| 88142 |
|
1,221 |
1,219 |
$25K |
| 72072 |
|
959 |
932 |
$25K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
723 |
644 |
$25K |
| 97022 |
|
2,868 |
880 |
$24K |
| 81329 |
|
207 |
205 |
$22K |
| 82105 |
|
2,186 |
2,126 |
$22K |
| 99205 |
Prolong outpt/office vis |
222 |
220 |
$22K |
| 97035 |
|
4,112 |
1,187 |
$22K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
15,566 |
14,285 |
$22K |
| 81243 |
|
427 |
425 |
$22K |
| 86923 |
|
963 |
848 |
$22K |
| 90651 |
|
1,967 |
1,910 |
$22K |
| 97802 |
|
270 |
264 |
$21K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
473 |
438 |
$21K |
| 86592 |
|
6,458 |
6,277 |
$20K |
| 92611 |
|
138 |
119 |
$20K |
| 88341 |
|
371 |
334 |
$20K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
241 |
231 |
$20K |
| 93296 |
|
1,373 |
1,298 |
$20K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
19,771 |
17,607 |
$20K |
| 90681 |
|
3,300 |
3,273 |
$19K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
11,441 |
8,901 |
$19K |
| 82947 |
|
2,986 |
2,839 |
$19K |
| Q3014 |
Telehealth originating site facility fee |
8,796 |
5,792 |
$19K |
| 83655 |
|
1,583 |
1,550 |
$18K |
| 76885 |
|
290 |
287 |
$18K |
| 95908 |
|
333 |
322 |
$18K |
| 49591 |
|
12 |
12 |
$18K |
| 95910 |
|
181 |
180 |
$18K |
| 73562 |
|
455 |
447 |
$18K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
30 |
28 |
$18K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,059 |
5,087 |
$18K |
| 74021 |
|
791 |
773 |
$17K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
185 |
179 |
$17K |
| 94645 |
|
668 |
596 |
$17K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
4,733 |
4,506 |
$17K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
3,261 |
3,042 |
$16K |
| A4649 |
Surgical supply; miscellaneous |
6,881 |
6,385 |
$16K |
| 73000 |
|
610 |
535 |
$15K |
| 82746 |
|
2,191 |
2,036 |
$15K |
| 96127 |
|
1,296 |
1,258 |
$15K |
| 80329 |
|
2,112 |
1,919 |
$15K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
310 |
294 |
$15K |
| 85379 |
|
4,732 |
4,504 |
$14K |
| 87088 |
|
3,964 |
3,723 |
$14K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
2,255 |
1,452 |
$14K |
| 36600 |
|
2,115 |
1,888 |
$14K |
| 77061 |
|
773 |
757 |
$14K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
914 |
678 |
$14K |
| 87590 |
|
702 |
698 |
$14K |
| 92551 |
|
406 |
395 |
$14K |
| 72132 |
|
159 |
137 |
$14K |
| 86140 |
|
4,150 |
3,726 |
$13K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
742 |
432 |
$13K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,645 |
1,497 |
$13K |
| 85660 |
|
3,269 |
3,067 |
$13K |
| 97116 |
|
920 |
445 |
$13K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,404 |
5,076 |
$13K |
| G0390 |
Trauma response team associated with hospital critical care service |
35 |
26 |
$13K |
| 82550 |
|
3,896 |
3,472 |
$12K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
14,593 |
13,359 |
$12K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
141 |
133 |
$12K |
| 72128 |
|
131 |
114 |
$12K |
| 82248 |
|
2,713 |
2,294 |
$12K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
7,542 |
6,011 |
$12K |
| 85651 |
|
6,842 |
6,221 |
$11K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,829 |
1,728 |
$11K |
| 15853 |
|
433 |
395 |
$11K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
3,590 |
2,922 |
$11K |
| 86762 |
|
2,472 |
2,453 |
$11K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
9,153 |
7,349 |
$11K |
| 95813 |
|
65 |
65 |
$11K |
| 87623 |
|
316 |
316 |
$11K |
| 0001A |
|
415 |
413 |
$10K |
| 76937 |
|
267 |
224 |
$10K |
| 93325 |
|
54 |
54 |
$10K |
| 95957 |
|
31 |
28 |
$10K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
498 |
434 |
$10K |
| 82570 |
|
2,560 |
2,367 |
$10K |
| 87205 |
|
3,051 |
2,792 |
$10K |
| 84436 |
|
867 |
849 |
$10K |
| 90474 |
|
2,705 |
2,695 |
$10K |
| 90670 |
|
3,944 |
3,916 |
$10K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
93 |
91 |
$9K |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,631 |
3,301 |
$9K |
| 82803 |
|
467 |
401 |
$9K |
| 90734 |
|
1,171 |
1,156 |
$9K |
| 80164 |
|
834 |
752 |
$9K |
| 93226 |
|
52 |
52 |
$9K |
| 93299 |
|
381 |
381 |
$9K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,956 |
2,416 |
$9K |
| 72129 |
|
95 |
84 |
$9K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,070 |
1,840 |
$9K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
11,753 |
10,680 |
$8K |
| 82043 |
|
1,979 |
1,923 |
$8K |
| 29130 |
|
170 |
157 |
$8K |
| 0072A |
|
271 |
271 |
$8K |
| 82150 |
|
2,047 |
1,928 |
$8K |
| 83970 |
|
345 |
310 |
$8K |
| A9505 |
Thallium tl-201 thallous chloride, diagnostic, per millicurie |
252 |
240 |
$8K |
| 90677 |
|
1,886 |
1,830 |
$8K |
| 97166 |
|
135 |
132 |
$8K |
| 0002A |
|
314 |
314 |
$8K |
| 72040 |
|
477 |
428 |
$8K |
| 88312 |
|
454 |
418 |
$8K |
| 84550 |
|
2,655 |
2,357 |
$8K |
| 0071A |
|
284 |
282 |
$8K |
| 70360 |
|
383 |
375 |
$8K |
| 73200 |
|
52 |
52 |
$7K |
| 36591 |
|
473 |
237 |
$7K |
| 92555 |
|
181 |
180 |
$7K |
| 99173 |
|
384 |
376 |
$7K |
| 74220 |
|
153 |
146 |
$7K |
| 86704 |
|
969 |
875 |
$7K |
| 80179 |
|
1,201 |
1,111 |
$7K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
313 |
307 |
$7K |
| 86706 |
|
846 |
768 |
$7K |
| 93225 |
|
53 |
53 |
$7K |
| 82247 |
|
1,669 |
1,317 |
$7K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
125 |
118 |
$7K |
| 85347 |
|
1,016 |
878 |
$6K |
| 87147 |
|
1,343 |
1,128 |
$6K |
| 74230 |
|
125 |
114 |
$6K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
1,772 |
399 |
$6K |
| OP278 |
|
13 |
12 |
$6K |
| 86141 |
|
997 |
877 |
$6K |
| 0004A |
|
217 |
217 |
$6K |
| D0140 |
Limited oral evaluation - problem focused |
2,833 |
2,743 |
$6K |
| 97163 |
|
122 |
113 |
$6K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
798 |
521 |
$5K |
| 99417 |
Prolong home eval add 15m |
92 |
90 |
$5K |
| 93312 |
|
12 |
12 |
$5K |
| 76376 |
|
233 |
221 |
$5K |
| 90675 |
|
108 |
44 |
$5K |
| 83520 |
|
502 |
464 |
$5K |
| 82784 |
|
687 |
552 |
$5K |
| 0042T |
|
78 |
69 |
$5K |
| 29705 |
|
71 |
70 |
$5K |
| 86920 |
|
98 |
88 |
$5K |
| 96368 |
|
234 |
165 |
$5K |
| 0054A |
|
204 |
198 |
$5K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
893 |
845 |
$5K |
| 86902 |
|
130 |
101 |
$5K |
| J3590 |
Unclassified biologics |
455 |
335 |
$5K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
163 |
158 |
$5K |
| 87420 |
|
239 |
238 |
$5K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,506 |
1,864 |
$5K |
| 82009 |
|
2,069 |
1,810 |
$5K |
| 81002 |
|
2,587 |
1,830 |
$4K |
| 88300 |
|
771 |
735 |
$4K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
85 |
70 |
$4K |
| 86038 |
|
411 |
392 |
$4K |
| 19083 |
|
16 |
14 |
$4K |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
313 |
309 |
$4K |
| 87075 |
|
845 |
756 |
$4K |
| 87184 |
|
344 |
310 |
$4K |
| 95885 |
|
76 |
69 |
$4K |
| 90723 |
|
4,823 |
4,761 |
$4K |
| 74022 |
|
120 |
119 |
$4K |
| 51701 |
|
99 |
99 |
$4K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
410 |
356 |
$4K |
| 70490 |
|
33 |
28 |
$4K |
| 92015 |
Determination of refractive state |
622 |
615 |
$4K |
| J1790 |
Injection, droperidol, up to 5 mg |
1,400 |
1,172 |
$4K |
| 90620 |
|
939 |
919 |
$4K |
| 76001 |
|
38 |
38 |
$3K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
12 |
12 |
$3K |
| J3360 |
Injection, diazepam, up to 5 mg |
626 |
534 |
$3K |
| 76881 |
|
42 |
41 |
$3K |
| 84156 |
|
2,048 |
1,828 |
$3K |
| 87902 |
|
14 |
14 |
$3K |
| OP229 |
|
61 |
55 |
$3K |
| 84153 |
|
313 |
299 |
$3K |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
4,921 |
4,582 |
$3K |
| J1940 |
Injection, furosemide, up to 20 mg |
1,376 |
828 |
$3K |
| 51702 |
|
132 |
87 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,047 |
952 |
$3K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
99 |
92 |
$3K |
| 81514 |
|
15 |
15 |
$3K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
16 |
14 |
$3K |
| J9370 |
Vincristine sulfate, 1 mg |
226 |
183 |
$3K |
| 82805 |
|
121 |
115 |
$3K |
| 73660 |
|
158 |
153 |
$3K |
| 78264 |
|
39 |
39 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
6,344 |
5,818 |
$3K |
| 80299 |
|
170 |
151 |
$3K |
| 45381 |
|
14 |
12 |
$3K |
| 87350 |
|
443 |
388 |
$3K |
| 74170 |
|
13 |
12 |
$3K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
28 |
13 |
$3K |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
293 |
240 |
$3K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
80 |
76 |
$3K |
| 94761 |
|
83 |
83 |
$2K |
| 90375 |
|
15 |
14 |
$2K |
| 88346 |
|
41 |
40 |
$2K |
| D7140 |
Extraction, erupted tooth or exposed root |
665 |
490 |
$2K |
| 73070 |
|
142 |
138 |
$2K |
| 77334 |
|
15 |
12 |
$2K |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
26 |
25 |
$2K |
| 86707 |
|
426 |
372 |
$2K |
| 87641 |
|
135 |
127 |
$2K |
| V2632 |
Posterior chamber intraocular lens |
226 |
162 |
$2K |
| 87430 |
|
351 |
349 |
$2K |
| 86705 |
|
517 |
444 |
$2K |
| 93924 |
|
15 |
13 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
37 |
33 |
$2K |
| 86870 |
|
81 |
63 |
$2K |
| 75625 |
|
15 |
13 |
$2K |
| 76857 |
|
75 |
73 |
$2K |
| 97168 |
|
45 |
42 |
$2K |
| 86787 |
|
192 |
190 |
$2K |
| 76506 |
|
26 |
26 |
$2K |
| 82397 |
|
108 |
100 |
$2K |
| 0124A |
|
89 |
88 |
$2K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
530 |
355 |
$2K |
| 71271 |
|
28 |
25 |
$2K |
| 86922 |
|
41 |
39 |
$2K |
| 0011A |
|
62 |
62 |
$2K |
| 82657 |
|
80 |
76 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
179 |
178 |
$2K |
| 96167 |
|
720 |
203 |
$2K |
| 86256 |
|
31 |
31 |
$2K |
| 86769 |
|
73 |
72 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
20 |
18 |
$2K |
| 90714 |
|
123 |
123 |
$2K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
32 |
23 |
$2K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
103 |
88 |
$2K |
| 82274 |
|
485 |
459 |
$2K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
25 |
25 |
$2K |
| 92556 |
|
25 |
25 |
$2K |
| 90649 |
|
88 |
88 |
$2K |
| D1120 |
Prophylaxis - child |
864 |
854 |
$2K |
| 87340 |
|
338 |
292 |
$2K |
| C1758 |
Catheter, ureteral |
197 |
171 |
$2K |
| J1953 |
Injection, levetiracetam, 10 mg |
508 |
364 |
$2K |
| 72070 |
|
53 |
50 |
$2K |
| 70355 |
|
95 |
94 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,339 |
852 |
$2K |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
663 |
569 |
$2K |
| J1245 |
Injection, dipyridamole, per 10 mg |
239 |
235 |
$2K |
| 84145 |
|
219 |
180 |
$1K |
| 87899 |
|
222 |
208 |
$1K |
| 82951 |
|
132 |
132 |
$1K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
88 |
71 |
$1K |
| 90707 |
|
1,050 |
1,037 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
409 |
353 |
$1K |
| 80074 |
|
57 |
57 |
$1K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
453 |
316 |
$1K |
| C1780 |
Lens, intraocular (new technology) |
102 |
97 |
$1K |
| 90716 |
|
1,207 |
1,183 |
$1K |
| 59020 |
|
25 |
24 |
$1K |
| 92522 |
|
28 |
28 |
$1K |
| 92060 |
|
67 |
63 |
$1K |
| 87507 |
|
15 |
12 |
$1K |
| 86580 |
|
263 |
255 |
$1K |
| 86003 |
|
26 |
24 |
$1K |
| 84480 |
|
148 |
147 |
$1K |
| 86480 |
|
71 |
70 |
$1K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
103 |
101 |
$1K |
| 82330 |
|
201 |
184 |
$1K |
| D0220 |
Intraoral - periapical first radiographic image |
1,549 |
1,480 |
$1K |
| J3535 |
Drug administered through a metered dose inhaler |
433 |
388 |
$1K |
| 85014 |
|
177 |
162 |
$1K |
| 93321 |
|
12 |
12 |
$1K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
325 |
301 |
$1K |
| 76882 |
|
36 |
36 |
$1K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
247 |
235 |
$1K |
| 82731 |
|
17 |
16 |
$1K |
| D0330 |
Panoramic radiographic image |
685 |
684 |
$1K |
| 86696 |
|
44 |
43 |
$993.38 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
159 |
157 |
$989.62 |
| 84703 |
|
374 |
357 |
$979.10 |
| G0466 |
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
12 |
12 |
$958.02 |
| 29530 |
|
18 |
17 |
$932.61 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
817 |
777 |
$929.01 |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
62 |
55 |
$928.64 |
| 84132 |
|
534 |
460 |
$926.38 |
| 0064A |
|
35 |
33 |
$906.36 |
| 78306 |
|
12 |
12 |
$898.22 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
42 |
42 |
$875.75 |
| 90732 |
|
28 |
28 |
$849.36 |
| 71100 |
|
28 |
25 |
$835.11 |
| C1753 |
Catheter, intravascular ultrasound |
33 |
25 |
$820.90 |
| 41800 |
|
13 |
13 |
$803.81 |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
31 |
29 |
$798.47 |
| 82977 |
|
147 |
137 |
$780.16 |
| 86695 |
|
46 |
45 |
$777.06 |
| C1729 |
Catheter, drainage |
55 |
36 |
$769.42 |
| 96156 |
|
164 |
149 |
$739.14 |
| 0346T |
|
12 |
12 |
$729.20 |
| 31575 |
|
12 |
12 |
$727.44 |
| 29540 |
|
12 |
12 |
$717.65 |
| 93280 |
|
54 |
52 |
$715.72 |
| 82575 |
|
95 |
92 |
$711.04 |
| 90674 |
|
152 |
152 |
$695.80 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
24 |
24 |
$686.51 |
| 64400 |
|
14 |
13 |
$677.61 |
| 20610 |
|
16 |
14 |
$662.06 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
143 |
126 |
$638.44 |
| 90633 |
|
2,412 |
2,371 |
$610.81 |
| 12013 |
|
12 |
12 |
$580.50 |
| D1206 |
Topical application of fluoride varnish |
138 |
138 |
$577.80 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
41 |
40 |
$573.11 |
| 87338 |
|
183 |
178 |
$561.82 |
| C1885 |
Catheter, transluminal angioplasty, laser |
13 |
12 |
$512.54 |
| 74248 |
|
12 |
12 |
$509.56 |
| 90656 |
|
253 |
250 |
$508.13 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
660 |
603 |
$507.24 |
| J3250 |
Injection, trimethobenzamide hcl, up to 200 mg |
82 |
65 |
$505.84 |
| 80185 |
|
53 |
48 |
$476.95 |
| 97018 |
|
186 |
45 |
$472.78 |
| 88302 |
|
29 |
29 |
$459.11 |
| 89051 |
|
180 |
133 |
$457.59 |
| D0120 |
Periodic oral evaluation - established patient |
360 |
356 |
$446.26 |
| J0173 |
Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg |
148 |
136 |
$442.06 |
| 86708 |
|
129 |
112 |
$436.99 |
| 70160 |
|
13 |
13 |
$428.68 |
| 0134A |
|
21 |
20 |
$424.50 |
| 90700 |
|
1,001 |
984 |
$420.62 |
| 86694 |
|
26 |
26 |
$417.36 |
| S5571 |
Insulin delivery device, disposable pen (including insulin); 3 ml size |
29 |
28 |
$416.12 |
| 87046 |
|
70 |
66 |
$409.31 |
| 86665 |
|
21 |
12 |
$407.56 |
| 80177 |
|
81 |
67 |
$402.26 |
| 75710 |
|
15 |
13 |
$382.58 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
116 |
107 |
$378.27 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
498 |
414 |
$364.64 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
64 |
50 |
$362.10 |
| 15854 |
|
14 |
12 |
$349.25 |
| 0052A |
|
12 |
12 |
$345.10 |
| 84295 |
|
237 |
199 |
$339.77 |
| D1110 |
Prophylaxis - adult |
146 |
143 |
$339.00 |
| 94762 |
|
15 |
15 |
$335.71 |
| 86618 |
|
12 |
12 |
$330.36 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
123 |
97 |
$281.23 |
| 93297 |
|
108 |
94 |
$273.37 |
| 85240 |
|
13 |
12 |
$264.78 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
28 |
27 |
$263.39 |
| 87045 |
|
55 |
52 |
$261.24 |
| 86308 |
|
72 |
70 |
$258.62 |
| 93298 |
|
16 |
16 |
$237.35 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
472 |
412 |
$236.99 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
160 |
135 |
$235.74 |
| 82375 |
|
49 |
46 |
$231.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
70 |
70 |
$230.66 |
| J3480 |
Injection, potassium chloride, per 2 meq |
168 |
119 |
$221.52 |
| D9310 |
|
606 |
600 |
$220.00 |
| 86317 |
|
46 |
40 |
$218.42 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
25 |
25 |
$211.12 |
| 86777 |
|
13 |
13 |
$204.72 |
| 86664 |
|
12 |
12 |
$203.12 |
| 0051A |
|
14 |
12 |
$193.58 |
| D1208 |
Topical application of fluoride, excluding varnish |
418 |
410 |
$177.35 |
| 90688 |
|
26 |
25 |
$173.76 |
| D0274 |
Bitewings - four radiographic images |
70 |
70 |
$170.82 |
| 82378 |
|
13 |
13 |
$170.40 |
| 84311 |
|
37 |
37 |
$169.03 |
| 89230 |
|
12 |
12 |
$168.15 |
| 86663 |
|
12 |
12 |
$163.71 |
| 83516 |
|
30 |
27 |
$157.22 |
| 90473 |
|
49 |
48 |
$149.55 |
| G0008 |
Administration of influenza virus vaccine |
406 |
339 |
$138.18 |
| 69209 |
|
12 |
12 |
$134.57 |
| 90756 |
|
16 |
16 |
$124.54 |
| 90662 |
|
17 |
15 |
$113.62 |
| 87449 |
|
13 |
12 |
$110.61 |
| 85246 |
|
13 |
12 |
$108.88 |
| 36000 |
|
13 |
12 |
$105.74 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
73 |
38 |
$105.73 |
| 82945 |
|
54 |
38 |
$96.89 |
| 90685 |
|
31 |
31 |
$95.01 |
| 90647 |
|
4,284 |
4,234 |
$93.60 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
142 |
112 |
$91.95 |
| 88112 |
|
13 |
12 |
$84.87 |
| 86431 |
|
13 |
13 |
$78.73 |
| 82533 |
|
13 |
13 |
$76.75 |
| 90619 |
|
78 |
75 |
$75.34 |
| 87185 |
|
27 |
24 |
$74.41 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
12 |
12 |
$73.49 |
| 82360 |
|
13 |
13 |
$72.96 |
| 86880 |
|
14 |
12 |
$67.30 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
12 |
12 |
$65.80 |
| 88311 |
|
14 |
13 |
$65.77 |
| D0150 |
Comprehensive oral evaluation - new or established patient |
29 |
27 |
$64.00 |
| 90648 |
|
13 |
13 |
$62.76 |
| J7510 |
Prednisolone oral, per 5 mg |
53 |
52 |
$61.46 |
| 82785 |
|
13 |
12 |
$58.51 |
| 84157 |
|
55 |
39 |
$57.43 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
46 |
43 |
$56.31 |
| 87106 |
|
14 |
13 |
$50.60 |
| 85060 |
|
15 |
12 |
$48.30 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
88 |
86 |
$40.37 |
| 91300 |
|
645 |
610 |
$39.00 |
| J0571 |
Buprenorphine, oral, 1 mg |
23 |
12 |
$38.62 |
| J0456 |
Injection, azithromycin, 500 mg |
18 |
16 |
$37.07 |
| A4550 |
Surgical trays |
68 |
62 |
$33.11 |
| D7210 |
Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth |
39 |
25 |
$33.00 |
| D0270 |
|
38 |
38 |
$31.00 |
| 84481 |
|
13 |
13 |
$30.00 |
| D0230 |
Intraoral - periapical each additional radiographic image |
60 |
51 |
$26.60 |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
21 |
17 |
$19.32 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
16 |
13 |
$17.11 |
| 86709 |
|
13 |
12 |
$11.97 |
| 83930 |
|
13 |
12 |
$11.36 |
| OP279 |
|
51 |
51 |
$10.01 |
| 91307 |
|
446 |
417 |
$9.00 |
| 91305 |
|
317 |
302 |
$5.00 |
| 91301 |
|
92 |
90 |
$3.00 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
33 |
29 |
$2.00 |
| OP259 |
|
31 |
21 |
$1.84 |
| D9222 |
|
61 |
60 |
$0.00 |
| Q0247 |
Injection, sotrovimab, 500 mg |
21 |
16 |
$0.00 |
| 91303 |
|
63 |
63 |
$0.00 |
| 90696 |
|
182 |
182 |
$0.00 |
| 90381 |
|
78 |
78 |
$0.00 |
| D0240 |
|
12 |
12 |
$0.00 |
| D9223 |
Deep sedation/general anesthesia - each subsequent 15 minute increment |
31 |
30 |
$0.00 |
| D7240 |
Removal of impacted tooth - completely bony |
13 |
13 |
$0.00 |
| 90744 |
|
17 |
12 |
$0.00 |
| D0210 |
Intraoral - complete series of radiographic images |
27 |
25 |
$0.00 |
| A4338 |
Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each |
14 |
12 |
$0.00 |
| 90710 |
|
369 |
367 |
$0.00 |
| 90380 |
|
88 |
88 |
$0.00 |
| 90671 |
|
124 |
123 |
$0.00 |
| 91312 |
|
86 |
85 |
$0.00 |
| 91313 |
|
21 |
20 |
$0.00 |